11/29
08:41 am
lucd
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% [Yahoo! Finance]
Medium
Report
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% [Yahoo! Finance]
11/25
01:53 pm
lucd
Lucid Diagnostics (NASDAQ:LUCD) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Lucid Diagnostics (NASDAQ:LUCD) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
08:15 am
lucd
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
Low
Report
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
11/15
01:42 am
lucd
Lucid Diagnostics (NASDAQ:LUCD) was downgraded by analysts at
Wall Stree
Low
Report
Lucid Diagnostics (NASDAQ:LUCD) was downgraded by analysts at
Wall Stree
11/13
08:15 am
lucd
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Medium
Report
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
11/13
08:11 am
lucd
Lucid Diagnostics (NASDAQ:LUCD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $3.00 price target on the stock.
Medium
Report
Lucid Diagnostics (NASDAQ:LUCD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $3.00 price target on the stock.
11/12
04:32 pm
lucd
Lucid Diagnostics Inc (LUCD) Q3 2025 Earnings Call Highlights: Strategic Growth Plans Amidst ... [Yahoo! Finance]
Medium
Report
Lucid Diagnostics Inc (LUCD) Q3 2025 Earnings Call Highlights: Strategic Growth Plans Amidst ... [Yahoo! Finance]
11/12
02:50 pm
lucd
Lucid Diagnostics Non-GAAP EPS of -$0.10 misses by $0.01, revenue of $1.21M misses by $0.14M [Seeking Alpha]
Low
Report
Lucid Diagnostics Non-GAAP EPS of -$0.10 misses by $0.01, revenue of $1.21M misses by $0.14M [Seeking Alpha]
11/12
02:47 pm
lucd
Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
08:00 am
lucd
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Low
Report
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
10/29
08:01 am
lucd
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
Low
Report
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
10/15
08:01 am
lucd
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
Medium
Report
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
10/14
01:07 am
lucd
Lucid Diagnostics (NASDAQ:LUCD) was upgraded by analysts at
Wall Street
Low
Report
Lucid Diagnostics (NASDAQ:LUCD) was upgraded by analysts at
Wall Street
10/6
08:09 am
lucd
Lucid Diagnostics (NASDAQ:LUCD) had its price target raised by analysts at Ascendiant Capital Markets from $7.75 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Lucid Diagnostics (NASDAQ:LUCD) had its price target raised by analysts at Ascendiant Capital Markets from $7.75 to $8.00. They now have a "buy" rating on the stock.
10/6
03:30 am
lucd
Lucid Diagnostics (NASDAQ:LUCD) was downgraded by analysts at
Wall Stree
Low
Report
Lucid Diagnostics (NASDAQ:LUCD) was downgraded by analysts at
Wall Stree
10/3
03:40 pm
lucd
Lucid Diagnostics (NASDAQ:LUCD) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Lucid Diagnostics (NASDAQ:LUCD) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/29
04:59 am
lucd
Lucid Diagnostics: Holding Onto Medicare Coverage Hopes [Seeking Alpha]
Neutral
Report
Lucid Diagnostics: Holding Onto Medicare Coverage Hopes [Seeking Alpha]
9/28
03:33 am
lucd
Lucid Diagnostics (NASDAQ:LUCD) was upgraded by analysts at
Wall Street
Neutral
Report
Lucid Diagnostics (NASDAQ:LUCD) was upgraded by analysts at
Wall Street
9/25
08:39 am
lucd
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors [Yahoo! Finance]
Low
Report
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors [Yahoo! Finance]
9/25
08:01 am
lucd
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
Low
Report
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
9/20
01:09 am
lucd
Lucid Diagnostics (NASDAQ:LUCD) was downgraded by analysts at
Wall Stree
Low
Report
Lucid Diagnostics (NASDAQ:LUCD) was downgraded by analysts at
Wall Stree
9/16
08:01 am
lucd
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
Low
Report
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
9/11
09:17 am
lucd
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
Low
Report
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
9/10
08:00 am
lucd
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Medium
Report
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
9/9
04:01 pm
lucd
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
High
Report
Lucid Diagnostics Announces Proposed Public Offering of Common Stock